On Tuesday afternoon, Amgen ($AMGN@US) reported solid quarter 2 earnings, including sales of $6.5 billion. This topped the $6.43 projected by analysts by 1.09% while also increasing 4.74% year over year. Furthermore, Amgen's earnings per share of $4.38 beat the estimate by 7.88%. Shares of Amgen were down 1.02% at press time.